Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Carl Holvey"'
Autor:
Matthew Murphy, Simon Erridge, Carl Holvey, Ross Coomber, James J. Rucker, Mikael H. Sodergren
Publikováno v:
Neuropsychopharmacology Reports, Vol 44, Iss 1, Pp 129-142 (2024)
Abstract Background Research on cannabis‐based medicinal products (CBMPs) in anxiety remains inconclusive due to a paucity of high‐quality evidence. Studies indicate a bidirectional relationship between generalized anxiety disorder (GAD) and slee
Externí odkaz:
https://doaj.org/article/e1416afede714fbe8b9d6becc52491c4
Autor:
Pim Ittiphakorn, Simon Erridge, Carl Holvey, Ross Coomber, James J. Rucker, Mikael H. Sodergren
Publikováno v:
Neuropsychopharmacology Reports, Vol 43, Iss 4, Pp 596-606 (2023)
Abstract Aim This study aims to analyze the health‐related quality of life (HRQoL) and safety outcomes in attention‐deficit/hyperactivity disorder (ADHD) patients treated with cannabis‐based medicinal products (CBMPs). Methods Patients were ide
Externí odkaz:
https://doaj.org/article/0b2c021ed51b4ba19421ca46d2d2ef2a
Autor:
Simon Erridge, Ophilia Leung, Carl Holvey, Ross Coomber, Sushil Beri, Shaheen Khan, Mark W. Weatherall, James J. Rucker, Michael W. Platt, Mikael H. Sodergren
Publikováno v:
Neuropsychopharmacology Reports, Vol 43, Iss 4, Pp 616-632 (2023)
Abstract Introduction While there is increasing evidence of the effects of cannabis‐based medicinal products (CBMPs) on health‐related quality of life (HRQoL), a major limitation of the current literature is the heterogeneity of studied CBMPs. Th
Externí odkaz:
https://doaj.org/article/d62ee49e28054088a17fabbb04c94272
Autor:
Kavyesh Vivek, Zekiye Karagozlu, Simon Erridge, Carl Holvey, Ross Coomber, James J. Rucker, Mark W. Weatherall, Mikael H Sodergren
Publikováno v:
Brain and Behavior, Vol 14, Iss 2, Pp n/a-n/a (2024)
Abstract Introduction The primary aim of this study was to assess changes in sleep‐specific health‐related quality of life (HRQoL) for those prescribed cannabis‐based medicinal products (CBMPs) for insomnia. Methods A case series of UK patients
Externí odkaz:
https://doaj.org/article/a3e581e5239f4578802925ef8044de7a
Autor:
Claire Wang, Simon Erridge, Carl Holvey, Ross Coomber, Azfer Usmani, Mohammed Sajad, Rahul Guru, Wendy Holden, James J. Rucker, Michael W. Platt, Mikael H. Sodergren
Publikováno v:
Brain and Behavior, Vol 13, Iss 7, Pp n/a-n/a (2023)
Abstract Introduction : There are limited therapeutic options for individuals with fibromyalgia. The aim of this study is to analyze changes in health‐related quality of life and incidence of adverse events of those prescribed cannabis‐based medi
Externí odkaz:
https://doaj.org/article/092efddbebfc4541b0177cefbc92d73e
Autor:
Devaki Nimalan, Michal Kawka, Simon Erridge, Mehmet Ergisi, Michael Harris, Oliver Salazar, Rayyan Ali, Katerina Loupasaki, Carl Holvey, Ross Coomber, Michael Platt, James J. Rucker, Shaheen Khan, Mikael H. Sodergren
Publikováno v:
Journal of Cannabis Research, Vol 4, Iss 1, Pp 1-4 (2022)
Abstract Introduction Palliative care aims to improve quality of life through optimal symptom control and pain management. Cannabis-based medicinal products (CBMPs) have a proven role in the treatment of chemotherapy-induced nausea and vomiting. Howe
Externí odkaz:
https://doaj.org/article/3a025f8c813141c1a05a680be5b3ed4e
Autor:
Simon Erridge, Oliver Salazar, Michal Kawka, Carl Holvey, Ross Coomber, Azfer Usmani, Mohammed Sajad, Sushil Beri, Jonathan Hoare, Shaheen Khan, Mark W. Weatherall, Michael Platt, James J. Rucker, Mikael H. Sodergren
Publikováno v:
Neuropsychopharmacology Reports, Vol 41, Iss 3, Pp 362-370 (2021)
Abstract Aim Cannabis‐based medicinal products (CBMPs) are prescribed with increased frequency, despite a paucity of high‐quality randomized controlled trials. The aim of this study is to analyze the early outcomes of the first series of patients
Externí odkaz:
https://doaj.org/article/054e64bcc4ca44e28126934b4cf0eba1
Autor:
Simon Erridge, Jess Kerr-Gaffney, Carl Holvey, Ross Coomber, Daniela A. Riano Barros, Urmila Bhoskar, Gracia Mwimba, Kavita Praveen, Chris Symeon, Simmi Sachdeva-Mohan, Mikael H. Sodergren, James J. Rucker
Publikováno v:
Therapeutic Advances in Psychopharmacology, Vol 12 (2022)
Introduction: Cannabis-based medicinal products (CBMPs) have been identified as a promising novel therapeutic for symptoms and comorbidities related to autism spectrum disorder (ASD). However, there is a paucity of clinical evidence of their efficacy
Externí odkaz:
https://doaj.org/article/db6f99cd87464b78b0f972fd3c2aece8
Autor:
Simon Erridge, Carl Holvey, Ross Coomber, Jonathan Hoare, Shaheen Khan, Michael W. Platt, James J. Rucker, Mark W. Weatherall, Sushil Beri, Mikael H. Sodergren
Publikováno v:
Neuropediatrics. 54:174-181
Background There is a paucity of high-quality evidence of the efficacy and safety of cannabis-based medicinal products in treatment of treatment-resistant epilepsy (TRE) in children. Methods A case series of children ( Results Thirty-five patients we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e1916968f0989fba574654e8bcd8a88
https://doi.org/10.1055/a-2002-2119
https://doi.org/10.1055/a-2002-2119
Autor:
Mehmet Ergisi, Simon Erridge, Michael Harris, Michal Kawka, Devaki Nimalan, Oliver Salazar, Katerina Loupasaki, Rayyan Ali, Carl Holvey, Ross Coomber, Michael Platt, James J Rucker, Mikael H Sodergren
Publikováno v:
Expert Review of Clinical Pharmacology. 15:487-495
Objectives Anxiety disorders are one of the most common reasons for seeking treatment with cannabis-based medicinal products (CBMPs). Current pharmacological treatments are variable in efficacy and the endocannabinoid system has been identified as a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9056549d772d590d13bc3c1a513e0278
https://doi.org/10.1080/17512433.2022.2020640
https://doi.org/10.1080/17512433.2022.2020640